Fulgent Genetics (FLGT) Net Margin (2015 - 2026)
Fulgent Genetics (FLGT) posted Net Margin of 34.58% for Q2 2026, up 0.9% sequentially from 34.9% in Q1 2026, and down 1141.0% YoY from 3.32% in Q2 2025.
Fulgent Genetics (FLGT) Net Margin (2015 - 2026) Analysis & Trends
Fulgent Genetics has reported Net Margin for 11 years, with the latest figure at 34.58% in Q2 2026.
- Quarterly Net Margin fell 1141.0% year-over-year to 34.58% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 35.01% (down 1819.0% YoY) and the FY2025 annual result came in at 18.75%, down 369.0% from the prior year.
- Net Margin grew to 34.58% in Q2 2026 per FLGT's latest filing, from 34.9% in the prior quarter.
- Over five years, Net Margin peaked at 47.95% in Q1 2022 and troughed at 5854.5% in Q4 2025.
- A 5-year average of 346.65% and a median of 18.48% in 2023 frame the typical range for Net Margin.
- The sharpest annual moves came in 2024 and 2025: Net Margin soared 17403 bps in 2024, then tumbled 584677 bps in 2025.
- Over 5 years, Net Margin stood at 28.8% in 2022, then plunged by 531 bps to 181.76% in 2023, then soared by 96 bps to 7.73% in 2024, then slumped by 75680 bps to 5854.5% in 2025, then soared by 99 bps to 34.58% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 34.58%, 34.9%, and 5854.5% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 13.89% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -8.89% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 18.47% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 5.52% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 27.82% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 17.86% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 22.67% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.02% |
| 10 | Fulgent Genetics | 557.44 Mn | 300.41 Mn | 25.68 Mn | -34.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.58% |
| Mar 31, 2026 | -34.90% |
| Dec 31, 2025 | -5,854.50% |
| Sep 30, 2025 | -7.86% |
| Jun 30, 2025 | -23.17% |
| Mar 31, 2025 | -15.69% |
| Dec 31, 2024 | -7.73% |
| Sep 30, 2024 | -20.42% |
| Jun 30, 2024 | -12.26% |
| Mar 31, 2024 | -20.88% |
| Dec 31, 2023 | -181.76% |
| Sep 30, 2023 | -15.48% |
| Jun 30, 2023 | -16.55% |
| Mar 31, 2023 | -23.18% |
| Dec 31, 2022 | -28.80% |
| Sep 30, 2022 | 1.27% |
| Jun 30, 2022 | 8.82% |
| Mar 31, 2022 | 47.95% |
| Dec 31, 2021 | 41.20% |
| Sep 30, 2021 | 53.64% |